TIS 0.00% 0.0¢ tissue therapies limited

Ann: Entitlement Offer Fully Subscribed, Further $0.57M Placement, page-15

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,445 Posts.
    lightbulb Created with Sketch. 160
    Yeah their frequent flyer points must just about be ready to expire so we might see a flurry!!!

    they had the surveys that the product would be accepted and that may not have changed but you are right that they will need to bring the awareness to the forefront of medical professionals again. medical pros are slow to convert but to start using this as a last resort is a no brainer as there is no downside to the medical pro. Then upon seeing results they will try it on earlier stage and the snowball begins depending on results and costs . medical insurers are the obvious target and their committees and I am unsure of how long the lead time is to get it on their approved list and priced accordingly so volume may be a little way down the track as many groups have monthly meetings but only quarterly introduction of new treatments etc etc. miss by a day and you end up 3-6 months late . Reminds me of our current applications how time can blow out.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.